Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA), for API manufacturing plant at Middleburg, New York, indicating closure of the audit and the inspection classification of this facility is determined as ‘Voluntary action indicated’ (VAI). Currently, the company does not have any sales from this plant.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
